Clinical Trials Directory

Trials / Completed

CompletedNCT00187226

A Study for Image-Guided Radiation Therapy in Pediatric Brain Tumors and Side Effects

A Phase II Study of Image-Guided Radiation Therapy for Pediatric CNS Tumors and Quantification of Radiation-Related CNS Effects

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
361 (actual)
Sponsor
St. Jude Children's Research Hospital · Academic / Other
Sex
All
Age
8 Months – 25 Years
Healthy volunteers
Not accepted

Summary

The purpose of the study was to determine if treating a limited volume of normal tissue surrounding the tumor or tumor bed using conformal radiation therapy would achieve similar rates of disease control compared to standard radiation therapy. The study was also conducted to examine the effect of irradiation on neurological, endocrine and cognitive function.

Detailed description

Radiation therapy is commonly used to treat a variety of brain tumors in children including ependymoma, craniopharyngioma and low- and high-grade glioma. The ability of the therapy to control brain tumors in children is known to depend on the tumor type, extent of resection and other clinical factors. Children who received radiation therapy on this study were evaluated for treatment failure at 12 months. In addition to the primary objective, the study was designed to explore the association between radiation dose and volume and a variety of neurological, endocrine and cognitive deficits up to 5 years after treatment.

Conditions

Interventions

TypeNameDescription
PROCEDURERadiation TherapyExternal Beam Radiation Therapy: 54Gy administered at 1.8Gy per day for low-grade glioma, craniopharyngioma and selected ependymoma.
PROCEDURERadiation TherapyExternal Beam Radiation Therapy: 59.4Gy administered at 1.8Gy per day for high-grade glioma and selected ependymoma.

Timeline

Start date
1997-06-01
Primary completion
2005-03-31
Completion
2022-02-01
First posted
2005-09-16
Last updated
2023-05-31
Results posted
2012-08-20

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00187226. Inclusion in this directory is not an endorsement.